Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,062 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study

NCT01663129

Conditions
Acute Lymphoblastic Leukemia, Bone Diseases, Bone Diseases, Metabolic, +31 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Stollery Children's Hospital Edmonton, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • Winnipeg Children's Hospital Winnipeg, Manitoba, Canada
View Trial Details
Completed

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

NCT00898079

Conditions
Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +43 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 192 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

NCT02071888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
  • John Theruer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

NCT00091091

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
View all 15 locations
View Trial Details
Completed

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT00722137

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • St. Francis Hosptial and Medical Center Hartford, Connecticut, United States
  • Center for Cancer Care at Goshen Hospital Goshen, Indiana, United States
  • Sinai Hospital Baltimore, Maryland, United States
  • Capitol Comp. Cancer Center Jefferson City, Missouri, United States
View all 150 locations
View Trial Details

Related conditions